» Articles » PMID: 37146581

Human Pluripotent-stem-cell-derived Organoids for Drug Discovery and Evaluation

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2023 May 5
PMID 37146581
Authors
Affiliations
Soon will be listed here.
Abstract

Human pluripotent stem cells (hPSCs) and three-dimensional organoids have ushered in a new era for disease modeling and drug discovery. Over the past decade, significant progress has been in deriving functional organoids from hPSCs, which have been applied to recapitulate disease phenotypes. In addition, these advancements have extended the application of hPSCs and organoids for drug screening and clinical-trial safety evaluations. This review provides an overview of the achievements and challenges in using hPSC-derived organoids to conduct relevant high-throughput, high-contentscreens and drug evaluation. These studies have greatly enhanced our knowledge and toolbox for precision medicine.

Citing Articles

Uterine organoids reveal insights into epithelial specification and plasticity in development and disease.

Rizo J, Ahmad V, Pru J, Winuthayanon S, Challa S, Kim T Proc Natl Acad Sci U S A. 2025; 122(5):e2422694122.

PMID: 39883834 PMC: 11804710. DOI: 10.1073/pnas.2422694122.


Revolutionising oral organoids with artificial intelligence.

Yang J, Fischer N, Ye Z Biomater Transl. 2025; 5(4):372-389.

PMID: 39872928 PMC: 11764189. DOI: 10.12336/biomatertransl.2024.04.004.


Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screening.

Qureshi A, Wehrle C, Ferreira-Gonzalez S, Jiao C, Hong H, Dadgar N JHEP Rep. 2024; 6(12):101164.

PMID: 39583095 PMC: 11584567. DOI: 10.1016/j.jhepr.2024.101164.


Telomeres: an organized string linking plants and mammals.

Di Pietro E, Burla R, La Torre M, Gonzalez-Garcia M, Dello Ioio R, Saggio I Biol Direct. 2024; 19(1):119.

PMID: 39568075 PMC: 11577926. DOI: 10.1186/s13062-024-00558-y.


Accelerated production of human epithelial organoids in a miniaturized spinning bioreactor.

Ye S, Marsee A, van Tienderen G, Rezaeimoghaddam M, Sheikh H, Samsom R Cell Rep Methods. 2024; 4(11):100903.

PMID: 39561715 PMC: 11705766. DOI: 10.1016/j.crmeth.2024.100903.


References
1.
Leibel S, Winquist A, Tseu I, Wang J, Luo D, Shojaie S . Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy. Sci Rep. 2019; 9(1):13450. PMC: 6748939. DOI: 10.1038/s41598-019-49696-8. View

2.
Wu B, Yang Z, Liu Y, Li J, Chen C, Li X . A chemically defined system supports two distinct types of stem cell from a single blastocyst and their self-assembly to generate blastoid. Cell Prolif. 2023; 56(6):e13396. PMC: 10280139. DOI: 10.1111/cpr.13396. View

3.
Wimmer R, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M . Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019; 565(7740):505-510. PMC: 7116578. DOI: 10.1038/s41586-018-0858-8. View

4.
Strikoudis A, Cieslak A, Loffredo L, Chen Y, Patel N, Saqi A . Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. Cell Rep. 2019; 27(12):3709-3723.e5. PMC: 6594401. DOI: 10.1016/j.celrep.2019.05.077. View

5.
Cruz N, Reddy R, McFaline-Figueroa J, Tran C, Fu H, Freedman B . Modelling ciliopathy phenotypes in human tissues derived from pluripotent stem cells with genetically ablated cilia. Nat Biomed Eng. 2022; 6(4):463-475. PMC: 9228023. DOI: 10.1038/s41551-022-00880-8. View